BioSpace News Archive

NANO-X IMAGING LTD (“Nanox” or the “Company,” Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in three investor conferences in the month of May 2024.

Palisade Bio, Inc. announced it has appointed Margery Fischbein to its Board of Directors.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its neuroendocrinology pipeline, including baseline characteristics data from its CAHtalyst™ Program.

Delcath Systems, Inc. announced it will host a conference call on May 14, 2024, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2024.

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it will release its financial results for the 1st quarter ended March 31st, 2024, on Wednesday, May 15th, 2024, before the market opens and will host a conference call and webcast at 8:30 am Eastern Time.

KromaTiD, a company focused on the research, development, and commercialization of single-cell genomics tools and services for the Cell and Gene Therapy Market, is launching GLP Genomic Integrity Karyotyping services at the 2024 American Society for Gene and Cell Therapy Meeting in Baltimore, Booth 2217, May 7–11.

Gilead Sciences, Inc. and Kite, a Gilead Company, will present 18 abstracts during the 2024 American Society of Clinical Oncology Annual Meeting.

MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT) today announced its first quarter ended March 31, 2024 financial results and updated its 2024 guidance.

Immuneering Corporation reported financial results for the first quarter ended March 31, 2024, and provided business updates.

Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, announced that the company will present at the 2024 RBC Capital Markets Global Healthcare Conference taking place May 14-15, 2024 in New York, NY.